ISSN: 2153-0645
Journal of Pharmacogenomics & Pharmacoproteomics received 613 citations as per Google Scholar report
Commentary
Impact of Bioinformatics and Pharmacogenomics on Personalized Cancer Treatment
DOI: 10.35248/2153-0645.23.14.056
Pharmacogenomics Challenges Faced by Clinical Pharmacists in Implementing Pharmacogenomics
DOI: 10.35248/2153-0645.23.14.057
Exploring the Benefits of Drug Dosage Formulation
DOI: 10.35248/2153-0645.23.14.059
Perspective
Symptoms of Parvovirus B19-Related Immune System Disorders
DOI: 10.35248/2153-0645.23.14.060
Post-Hematopoeitic Stem Cell Transplantation and Potential Benefits of Utilizing Clinical Proteomics
DOI: 10.35248/2153-0645.23.14.061
Pharmacoproteomics and its Impact on Developing the Potential of Targeted Therapeutics
DOI: 10.35248/2153-0645.23.14.062
Short Communication
Potential Benefits of Genomics and Proteomics to Manage Cardiovascular Risk in Autoimmune Diseases
DOI: 10.35248/2153-0645.23.14.065
Opinion Article
Benefits and Limitations of using Toxicoproteomics for Diagnosing Liver Injury
DOI: 10.35248/2153-0645.23.14.064
Challenges Facing the Adoption of Personalized Medicine for Diagnosing and Treating Inflammatory Bowel Disease
DOI: 10.35248/2153-0645.23.14.063
Pharmacological Drug Delivery and Transformative Therapies for Liver Diseases Technologies
DOI: 10.35248/2153-0645.23.14.058